Tag: Bioventrix

Industry Focus Areas, Medical

FDA approves Bioventrix trial for Revivent TC heart failure device

June 1, 2016

Via: Mass Device

Bioventrix said today it won FDA investigational device exemption approval to initiate a pivotal trial of its Revivent TC transcatheter ventricular enhancement system device designed for reshaping and restoring the left ventricle. Revivent is designed to eliminate the need for […]